Words matter. We should have more patients and fewer "healthcare consumers." The term is terribly harsh, since it's all about taking.
Other Science News
As if having Gwyneth Paltrow's "lifestyle" brand in the U.S. isn't bad enough, the company's vaginal egg-lined path now leads north, with products available to be shipped to Canada. Now Canadians, too, will be able to waste a ton of money on GOOP's nonsense.
The CDC is told seven words are no longer allowed in their documents. Banning words and thoughts doesn't work, just ask George Carlin. Do they think it will somehow work now?
Waze, a driving navigation app, has moved from traffic advisor to traffic director as it's user base grows. But does this new algorithmic overlord have special responsibilities?
Somebody is pulling a conceptual fast-one over those gullible enough to believe it, both on and off the ice. It's the selling of a false reality, rooted in a baseless premise that changing a uniform's color can make athletes skate faster. Absurd doesn't begin to describe this.
Just about 10 years ago, ACSH published the first edition of our booklet Celebrities vs. Science, calling out a number of well-known personalities for promulgating non-scientific nonsense. Unfortunately, that trend has continued, as a new essay points out.
For those with celiac disease, everything that enters into their bodies must be assessed for the presence of gluten. A new recommendation from FDA extends this precaution from food ingredients to oral medications.
When it comes to medical developments, it was an exciting year in the pursuit of what was once impossible. Here are some top picks that genuinely are changing the medical and tech landscape.
The senior senator from Arizona, diagnosed with brain cancer in July, was hospitalized for "normal side effects of his ongoing cancer therapy." Here's what that means.
Typically, the peer review process is "single-blind," meaning that reviewers are aware of an author's identity. Yet it can also be "double-blind," where neither the author nor the reviewers know each other's identity. But, bottom line: Does knowing who wrote a paper influence the reviewer's opinion of it?
The Boogyman was a creation used to control children's behavior. That said, it has no role in the debate over public health policy.
A recent study published in Annals of Internal Medicine presents a cost analysis of personalized blood sugar goals for diabetic patients. While its numerical conclusions may not be as precise as the figures would make you believe, it does contain some interesting information.